Endometrial cancer: open trials in Portugal

• NCT07262619

  EIK1005-002: A Clinical Research Study Evaluating EIK1005, a Werner Helicase Inhibitor, as Monotherapy and in Combination With Pembrolizumab in Participants With Advanced Solid Tumors Including Microsatellite Instability High (MSI-H) Tumors

  Trial Treatment · Phase 1/2 · Eikon Therapeutics

  Hospital da Luz Lisboa, Lisbon · Hospital De Santa Maria, Lisbon · Unidade Local de Saúde (ULS) Loures Odivelas, Loures · Instituto Português de Oncologia do Porto Francisco Gentil, E.P.E. (IPO Porto), Porto

  Registry updated 2026-10-30

• NCT07109726

  A Phase 1/2 Trial of TER-2013 in Patients With Solid Tumors Harboring AKT/PI3K/PTEN Pathway Alterations

  Trial Treatment · Phase 1/2 · Terremoto Biosciences Inc.

  Centro Clínico Académico de Braga, Braga · START Lisboa, Lisbon

  Registry updated 2026-10-28

• NCT07022483

  A Study of Trastuzumab Deruxtecan Versus Standard of Care Chemotherapy for HER2-Expressing (IHC 3+/2+) Endometrial Cancer in Adjuvant Setting

  Trial Treatment · Phase 3 · Daiichi Sankyo

  Unidade Local de Saúde de Coimbra, E.P.E., Coimbra · Hospital da Luz, S.A, Lisbon · Instituto Portugues de Oncologia do Porto Francisco Gentil, E.P.E., Porto · Unidade Local de Saúde de Gaia/Espinho, E. P. E, Vila Nova de Gaia

  Registry updated 2026-10-27

• NCT06330064

  A Study to Evaluate the Efficacy and Safety of Ifinatamab Deruxtecan (I-DXd) in Subjects With Recurrent or Metastatic Solid Tumors (IDeate-PanTumor02)

  Trial Treatment · Phase 1/2 · Daiichi Sankyo

  Champalimaud Clinical Centre, Lisbon · Unidade Local De Saude De Santa Maria E.P.E., Lisbon · Instituto Portugues de Oncologia de Lisboa Francisco Gentil, E.P.E., Lisbon · Instituto Portugues de Oncologia do Porto Francisco Gentil, E.P.E., Porto · Unidade Local De Saude De Santo Antonio E.P.E., Porto

  Registry updated 2026-10-26

All Endometrial cancer trials and the map

This page is not medical advice. Talk to your doctor before contacting a trial.

Report an error